Xvision’s milestone, Aurora Spine’s record Q2 and more: 4 device company notes

Surgalign’s FDA clearance and three more updates from spine device companies since Aug. 24.

Advertisement

1. Surgalign’s Cortera spinal fixation system received FDA 510(k) clearance.

2. Xtant Medical entered an agreement to sell common stock and warrants to investors. The investment is expected to be about $9.75 million.

3. Aurora Spine saw record sales in the second quarter of 2022. Second-quarter sales of $4.1 million represented a 67.7 percent increase year over year.

4. Augmedics’ Xvision spine system was used in its 2,000th case. John Stevenson, MD, performed the company’s milestone case in Gainesville, Fla.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.